General Information of the Compound
Compound ID
CP0407890
Compound Name
1-ethyl-3-methyl-8-(1H-pyrazol-4-yl)-7H-purine-2,6-dione
    Show/Hide
Structure
Formula
C11H12N6O2
Molecular Weight
260.257
Canonical SMILES
CCn1c(=O)n(C)c2nc([nH]c2c1=O)-c1cn[nH]c1
    Show/Hide
InChI
InChI=1S/C11H12N6O2/c1-3-17-10(18)7-9(16(2)11(17)19)15-8(14-7)6-4-12-13-5-6/h4-5H,3H2,1-2H3,(H,12,13)(H,14,15)
    Show/Hide
InChIKey
CVWDHPQRKZZNAX-UHFFFAOYSA-N
Physicochemical Property
logP
-0.1667
Rotatable Bonds
2
Heavy Atom Count
19
Polar Areas
101.36
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 22266753
SID: 49848742
ChEMBL ID
CHEMBL264952
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01278, Adenosine receptor A2b
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 120 nM
   TI
   LI
   LO
   TS